China NMPA Product Recall - Treponema pallidum antibody detection kit (electrochemiluminescence method)

On June 12, 2019, the National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Roche Diagnostics GmbH, reported by its subsidiary, Roche Diagnostics Products (Shanghai) Co., Ltd. The recall specifically pertains to the "Treponema pallidum Antibody Detection Kit (Electrochemiluminescence Method)," identified by Registration Certificate No.: 20183402558. The primary reason for this corrective action is the discovery of potential errors within the product's instructions for use. Such inaccuracies could potentially impact the proper application or interpretation of test results, thus compromising diagnostic reliability and patient safety. Under the NMPA's regulatory framework, Roche Diagnostics GmbH is proactively removing the affected kits from distribution to rectify these instructional discrepancies. A Class III recall indicates that the use of or exposure to the product is not likely to cause adverse health consequences, but a correction is necessary. Further specific details regarding the affected models, specifications, and batch numbers are provided in the "Medical Device Recall Event Report Form" accompanying the NMPA's official announcement. This action highlights the manufacturer's commitment, under NMPA's oversight, to ensuring the integrity and safety of medical diagnostic products within the Chinese market.